Cytocom updates investigational new drug application for phase 2 clinical trial of CYTO-205 for treatment of COVID-19

Cytocom updates investigational new drug application for phase 2 clinical trial of CYTO-205 for treatment of COVID-19

FORT COLLINS -- Cytocom, Inc. today provided an update regarding its CYTO-200 portfolio of clinical programs. Cytocom said it has submitted an Investigational New Drug (IND) application with... Read More

Tuesday February 16, 2021 0 comments Tags: Fort Collins, Cytocom, COVID-19, CYTO-205, Michael Handley

IN Sponsors

Content Garden ad

Browse

AlloSource announces first patients implanted with AlloWrap Amniotic Membrane in clinical study for two-level anterior cervical discectomy and fusion procedures
AlloSource announces first patients implanted with AlloWrap Amniotic Membrane in clinical study for two-level anterior cervical discectomy and fusion procedures
Blue Canyon Technologies to develop 6 additional DARPA Blackjack satellites
Blue Canyon Technologies to develop 6 additional DARPA Blackjack satellites
CSU vaccine research advances to develop coronavirus vaccine for next pandemic
CSU vaccine research advances to develop coronavirus vaccine for next pandemic
Ampio adds new hospitals in trial for inhalation treatment of COVID-19
Ampio adds new hospitals in trial for inhalation treatment of COVID-19
Redbox selects SpotX for video monetization across its free streaming platform
Redbox selects SpotX for video monetization across its free streaming platform

Entrepreneurial by Nature


Colorado Entreprenerial by Nature
Copyright InnovatioNews LLC 2015. All Rights Reserved.